GSK completes acquisition of Boston-based, clinical-stage biopharma company, IDRx, Inc.
GSK (GSK) plc announced that it has completed the acquisition of IDRx, Inc., a Boston-based, clinical-stage biopharmaceutical company dedicated ...
Learn about Pseudoangiomatous Stromal Hyperplasia (PASH) of the breast, its diagnosis, hormonal influences, and holistic ...
Joint injury induces rapid and sustained diversification of resident and infiltrating synovial macrophage phenotypes, underpinning osteoarthritis-associated synovitis.